Literature DB >> 17565426

Overlapping free bone graft with galea-pericranium in reconstruction of the anterior skull base to prevent CSF leak and sequestrum formation.

T Abe1, M Goda, T Kamida, M Fujiki, H Kobayashi, T Nakano, T Mori, T Watanabe, M Suzuki.   

Abstract

Background. Reconstruction of the skull base after resection of a tumour is important to prevent postoperative complications such as infectionsand cerebrospinal fluid (CSF) leakage. Several reconstructive methods of the anterior skull base have been reported but, their long-term results are not clear. Methods. We describe a technique used after removal of an olfactory neuroblastoma with infiltration of the skull base. The reconstructed dura was covered with a galeal patch, a replicated galeal-pericranial flap, a graft from the inner table of skull, and a vascularised galeal-pericranial flap placed on the skull base defect. All layers were fixed with fibrin glue. Conclusion. Three dimensional computed tomography (3D-CT) at bone window settings demonstrated the bone graft covered the bone defect and was not absorbed and after 11 years there have been no signs of tumour regrowth or complications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565426     DOI: 10.1007/s00701-007-1227-9

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  2 in total

1.  The utility of 3-dimensional-printed models for skull base meningioma surgery.

Authors:  Xiao-Yu Guo; Zhen-Qiang He; Hao Duan; Fu-Hua Lin; Guan-Hua Zhang; Xiang-Heng Zhang; Zheng-He Chen; Ke Sai; Xiao-Bing Jiang; Zhen-Ning Wang; Tian Xie; Zhong-Ping Chen; Yong-Gao Mou
Journal:  Ann Transl Med       Date:  2020-03

2.  Pedicle Galeo-pericranial Flap Augmentation in Salvage Frontotemporal Cranioplasty: Additional 'Neurosurgeon-friendly' Reconstruction Technique of Aesthetic Neurosurgery in Superficial Temporal Artery Branch Compromised Host.

Authors:  Ichiro Takumi; Masataka Akimoto; Kouhei Hironaka; Koji Adachi; Takashi Kon; Takashi Matsumori; Yuichiro Tanaka; Akio Morita
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-07-12       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.